^
Association details:
| Biomarker: | LY9 expression |
|---|---|
| Cancer: | Mantle Cell Lymphoma |
| Drug Class: | T-lymphocyte cell therapy |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Abstract 3250: CD229-targeted CAR T cell therapy for the treatment of B cell lymphoma
Published date:
08/15/2020
Excerpt:
...CD229 CAR T cells were also able to effectively kill primary cells from 4/4 mantle cell lymphoma patients and 3/3 B-CLL patients....CD229 CAR T cells are a promising candidate for the treatment of B cell lymphoma as evidenced by the consistent expression of CD229...
DOI:
10.1158/1538-7445.AM2020-3250
